<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Respir Res</journal-id><journal-id journal-id-type="iso-abbrev">Respir Res</journal-id><journal-title-group><journal-title>Respiratory Research</journal-title></journal-title-group><issn pub-type="ppub">1465-9921</issn><issn pub-type="epub">1465-993X</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC12093805</article-id><article-id pub-id-type="publisher-id">3269</article-id><article-id pub-id-type="doi">10.1186/s12931-025-03269-8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Use of quantitative CT chest imaging to derive and assess a radiographic phenotype of deployment-related constrictive bronchiolitis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bell</surname><given-names>Alexander J.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Masotti</surname><given-names>Maria</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Ram</surname><given-names>Sundaresh</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Pappas</surname><given-names>Gregory</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Miller</surname><given-names>Robert F.</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Kazerooni</surname><given-names>Ella A.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Hatt</surname><given-names>Charles R.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Han</surname><given-names>MeiLan K.</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Richmond</surname><given-names>Bradley W.</given-names></name><xref ref-type="aff" rid="Aff6">6</xref><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Falvo</surname><given-names>Michael J.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Galban</surname><given-names>Craig J.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Osterholzer</surname><given-names>John J.</given-names></name><address><email>oster@umich.edu</email></address><xref ref-type="aff" rid="Aff7">7</xref><xref ref-type="aff" rid="Aff10">10</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00jmfr291</institution-id><institution-id institution-id-type="GRID">grid.214458.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7347</institution-id><institution>Department of Radiology, </institution><institution>University of Michigan, </institution></institution-wrap>Ann Arbor, MI USA </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00jmfr291</institution-id><institution-id institution-id-type="GRID">grid.214458.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7347</institution-id><institution>Department of Biostatistics, </institution><institution>University of Michigan, </institution></institution-wrap>Ann Arbor, MI USA </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03czfpz43</institution-id><institution-id institution-id-type="GRID">grid.189967.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7398</institution-id><institution>Department of Radiology and Imaging Sciences, </institution><institution>Emory University, </institution></institution-wrap>Atlanta, GA USA </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02j15s898</institution-id><institution-id institution-id-type="GRID">grid.470935.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 0413 1091</institution-id><institution>Wallace H. Coulter Department of Biomedical Engineering, </institution><institution>Emory University, Georgia Institute of Technology, </institution></institution-wrap>Atlanta, GA USA </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/003g0xf19</institution-id><institution-id institution-id-type="GRID">grid.422069.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 0420 0456</institution-id><institution>Airborne Hazards and Burn Pits Center of Excellence, VA New Jersey Health System, </institution></institution-wrap>East Orange, NJ USA </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05dq2gs74</institution-id><institution-id institution-id-type="GRID">grid.412807.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9916</institution-id><institution>Division of Allergy, Pulmonary, and Critical Care Medicine, </institution><institution>Vanderbilt University Medical Center, </institution></institution-wrap>Nashville, TN USA </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00jmfr291</institution-id><institution-id institution-id-type="GRID">grid.214458.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7347</institution-id><institution>Division of Pulmonary and Critical Care Medicine, </institution><institution>University of Michigan, </institution></institution-wrap>2215 Fuller Rd (111G), Ann Arbor, MI 48105 USA </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01b3ys956</institution-id><institution-id institution-id-type="GRID">grid.492803.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 0420 5919</institution-id><institution>Department of Veterans Affairs Medical Center, </institution></institution-wrap>Nashville, TN USA </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05vt9qd57</institution-id><institution-id institution-id-type="GRID">grid.430387.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8796</institution-id><institution>New Jersey Medical School, </institution><institution>Rutgers University, </institution></institution-wrap>Newark, NJ USA </aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/018txrr13</institution-id><institution-id institution-id-type="GRID">grid.413800.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 0419 7525</institution-id><institution>Pulmonary Section, </institution><institution>VA Ann Arbor Health System, </institution></institution-wrap>Ann Arbor, MI USA </aff></contrib-group><pub-date pub-type="epub"><day>21</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>21</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>26</volume><elocation-id>195</elocation-id><history><date date-type="received"><day>6</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>6</day><month>5</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Efforts to phenotype veterans that developed respiratory symptoms following deployments to the Southwest Asia Theater of Military Operation have been limited by the insensitivity of current non-invasive testing to objectively identify deployment-related constrictive bronchiolitis and other features of chronic lung injury. In this study, we derived a quantitative CT (QCT)-based radiographic phenotype of biopsy-proven deployment-related constrictive bronchiolitis (DRCB) and assessed its ability to assist in the phenotyping of non-biopsied formerly deployed symptomatic veterans.</p></sec><sec><title>Methods</title><p id="Par2">QCT analysis combined with demographic, physiologic, symptom, and exposure data was obtained from three cohorts: military personnel with biopsy-proven deployment-related constrictive bronchiolitis (DRCB, <italic>n</italic>&#x02009;=&#x02009;37), formerly deployed symptomatic veterans (FDSV, <italic>n</italic>&#x02009;=&#x02009;71), and asymptomatic civilians (Control, <italic>n</italic>&#x02009;=&#x02009;98). Differences in unadjusted QCT metrics and demographic variables between cohorts were identified and further assessed by principal component analysis. Thereafter, adjusted data from the DRCB cohort was used to derive a QCT-based radiographic phenotype of DRCB expressed as a DRCB-Probability Index (DRCB-PI). Application of the DRCB-PI to the FDSV cohort was used to assess additional phenotypic metrics associated with the DRCB phenotype (DRCB-PI&#x02009;&#x0003e;&#x02009;0.5).</p></sec><sec><title>Results</title><p id="Par3">Individual unadjusted QCT metrics for functional small airways disease and high attenuation area were elevated in DRCB and FDSV cohorts (relative to Control). Primary component analysis revealed that DRCB and FDSV cohorts overlapped and were distinguished from the Control cohort. The FDSV subjects whose DRCB-PI was &#x0003e;&#x02009;0.5 had greater evidence of small airways disease (assessed by oscillometry and QCT) and self-reported more intense immediate health effects to their exposures to military burn pit smoke, and sand and dust.</p></sec><sec><title>Conclusions</title><p id="Par4">Application of a QCT-derived radiographic phenotype of DRCB identified a subset of veterans with evidence of abnormal small airways and more severe self-reported health effects following inhalational exposures during military deployment. Future studies incorporating QCT may help establish non-invasive strategies to detect DRCB and other forms of chronic lung injury.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s12931-025-03269-8.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Phenotypes</kwd><kwd>Airway disease</kwd><kwd>Environmental exposures</kwd><kwd>Military deployment</kwd><kwd>Lung injury</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000005</institution-id><institution>U.S. Department of Defense</institution></institution-wrap></funding-source><award-id>GW16015</award-id><award-id>GW16015</award-id><award-id>GW16015</award-id><award-id>GW16015</award-id><award-id>GW16015</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000738</institution-id><institution>U.S. Department of Veterans Affairs</institution></institution-wrap></funding-source><award-id>Merit Review Award (JJO)</award-id><award-id>Merit Review Award (JJO)</award-id><award-id>Merit Review Award (JJO)</award-id><award-id>Merit Review Award (JJO)</award-id><award-id>Merit Review Award (JJO)</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; BioMed Central Ltd., part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par5">Chronic respiratory symptoms are commonly reported among the approximately 3.7&#x000a0;million U.S. military personnel deployed to the Southwest Asia Theater of Military Operations <xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>. A recent study <xref ref-type="bibr" rid="CR5">5</xref> identified associations between exposures to burn pit smoke and military occupational vapors, gases, dust, and fumes with increased chronic respiratory symptoms. Additionally, asthma, COPD, and hypertension (defined by diagnostic codes) were more frequent amongst military personnel deployed to bases with open air burn pits <xref ref-type="bibr" rid="CR6">6</xref>. However, diagnoses are often elusive in as many as one-third of individuals despite a thorough non-invasive evaluation <xref ref-type="bibr" rid="CR7">7</xref>.</p><p id="Par6">Constrictive bronchiolitis (CB) has been identified in a subset of formerly deployed military personnel that underwent surgical lung biopsy following an inconclusive non-invasive evaluation for chronic respiratory symptoms <xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>. In addition to CB, subsequent studies have identified additional histopathologic abnormalities in many subjects suggestive of multi-compartmental lung injury including findings of chronic airway inflammation, interstitial abnormalities, airspace enlargement, and vascular remodeling <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>. Unfortunately, non-invasive diagnostic approaches for deployment-related CB (DRCB) are difficult owing to the insensitivity of conventional pulmonary function tests (PFTs) and reliance on qualitative impressions of high-resolution CT (HRCT) scans <xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>. This has prompted calls to develop new non-invasive methods to identify and phenotype DRCB and related patterns of chronic lung injury <xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR12">12</xref>.</p><p id="Par7">Parametric response mapping (PRM) has emerged as an effective form of quantitative CT (QCT) analysis that quantifies multiple radiographic abnormalities, including features of functional small airways disease (fSAD), by measuring differences in lung density obtained from spatially aligned inspiratory and expiratory HRCT images <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>. Using PRM, we previously demonstrated that %PRM<sup>fSAD</sup> in military personnel with biopsy-proven DRCB is increased relative to asymptomatic control subjects and subjects with spirometric evidence of mild to moderate COPD <xref ref-type="bibr" rid="CR18">18</xref>. This finding identified %PRM<sup>fSAD</sup> as a potential QCT indicator of DRCB, yet a more complete QCT phenotype of DRCB using multiple PRM metrics has not been assessed.</p><p id="Par8">In the current study, we performed PRM analysis on HRCT scans obtained from subjects with biopsy proven DRCB, non-biopsied formerly deployed symptomatic veterans (FDSV), and asymptomatic control subjects to identify QCT metrics associated with biopsy-proven DRCB. We then derived a radiographic phenotype of DRCB and assessed its ability to enhance the phenotyping of the FDSV cohort when incorporated with additional metrics of pulmonary function, airway wall thickness and ventilation, symptoms, and inhalational exposures.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Study populations</title><p id="Par9">Three separate cohorts of subjects were used in this study: (1) military personnel with DRCB evaluated at Vanderbilt Medical Center [DRCB, <italic>n</italic>&#x02009;=&#x02009;37, detailed in <xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR18">18</xref>)], (2) formerly deployed symptomatic veterans evaluated at the New Jersey VA War Related Illness and Injury Study Center (FDSV, <italic>n</italic>&#x02009;=&#x02009;71), and (3) asymptomatic non-military adults from A Study to Obtain Normal Values of Inflammatory Variables from Healthy Subjects [Control, <italic>n</italic>&#x02009;=&#x02009;98, detailed in: <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. All subjects in the Control cohort consented to participate. Consent to participate was waived (following IRB review) for the DRCB and FDSV cohorts since their data were obtained for clinical indications. The study was conducted in accordance with approvals obtained following IRB review at the VA Ann Arbor Health System (1754681), the University of Michigan (HUM00246250), the Vanderbilt Medical Center, and the VA New Jersey Health System. Additional descriptions of the cohorts are provided below and in the Supplemental Material.</p></sec><sec id="Sec4"><title>Assessments</title><p id="Par10">Demographic variables including age, gender, tobacco use history, and body mass index (BMI) were recorded for all subjects.</p><p id="Par11">All subjects underwent complete pulmonary function testing (PFT), including spirometry (FEV<sub>1</sub>, FEV<sub>1</sub>/FVC), body plethysmography (TLC, RV/TLC), and diffusing capacity of carbon monoxide (DLCO) according to American Thoracic Society guidelines <xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref> with results reported as a percent predicted <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref> (see Supplemental Material). The FDSV subjects also underwent respiratory oscillometry (R5, R5-R20, X5, AX) performed in accordance with standard guidelines <xref ref-type="bibr" rid="CR26">26</xref> as reported previously <xref ref-type="bibr" rid="CR27">27</xref> and further detailed in the Supplemental Material.</p><p id="Par12">Volumetric HRCT scans were obtained at full inspiration and at approximate residual volume for all subjects. Scanner type and protocols are detailed in the Online Supplemental Material (e&#x02013; Table&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>).</p><p id="Par13">The FDSV subjects were asked to self-report the intensity of health effects in response to smoke from burn pits, sand and dust, and petrochemicals during their deployment(s) that were graded on a scale from 1 to 4 as follows: (1) no noticeable health effects, (2) mild effects or symptoms that did not affect ability to conduct physical activities, (3) moderate effects or symptoms that had some effect on physical activity, or (4) severe effects or symptoms that markedly impaired physical activity and/or required medical treatment. Subjects also indicated the presence or absence of current cough, wheeze, and/or shortness of breath.</p></sec><sec id="Sec5"><title>QCT analysis</title><p id="Par14">Parametric response mapping was applied to all paired HRCT scans as previously described <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR28">28</xref> and further detailed in the Online Supplemental Material. Each voxel, consisting of Hounsfield units at inspiration and expiration, were classified based on a scheme of predetermined thresholds <xref ref-type="bibr" rid="CR14">14</xref> and Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> as: normal (PRM<sup>Norm</sup>), functional small airways disease (PRM<sup>fSAD</sup>), emphysema (PRM<sup>Emph</sup>), and high attenuation area (PRM<sup>HAA</sup>). The relative lung volumes, calculated as the sum of all voxels within a class normalized to the sum of all voxels within the expiratory lungs multiplied by 100, were used as global measures. QCT measurements of airway wall area, pi10 (wall thickness of airways with 10&#x000a0;mm internal perimeter), and Jacobian Mean (a measure of total lung ventilation) were performed as previously described <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>.</p><p id="Par15">
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Thresholds for parametric response mapping</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">PRM<sup>Norm</sup></th><th align="left">PRM<sup>fSAD</sup></th><th align="left">PRM<sup>HAA</sup></th><th align="left">PRM<sup>Emph</sup></th></tr></thead><tbody><tr><td align="left">Inspiration</td><td align="left">-950&#x02009;&#x02264;&#x02009;to &#x0003c; -810 HU</td><td align="left">-950&#x02009;&#x02264;&#x02009;to &#x0003c; -810 HU</td><td align="left">-810&#x02009;&#x02264;&#x02009;to &#x0003c; -250 HU</td><td align="left">-1000&#x02009;&#x02264;&#x02009;to &#x0003c; -950 HU</td></tr><tr><td align="left">Expiration</td><td align="left">-856&#x02009;&#x02264;&#x02009;to &#x0003c; -250 HU</td><td align="left">-1000&#x02009;&#x02264;&#x02009;to &#x0003c; -856 HU</td><td align="left">-1000&#x02009;&#x02264;&#x02009;to &#x0003c; -250 HU</td><td align="left">-1000&#x02009;&#x02264;&#x02009;to &#x0003c; -856 HU</td></tr></tbody></table><table-wrap-foot><p>* HU, Hounsfield units</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec6"><title>Statistical analysis</title><p id="Par16">Statistical analysis was performed using R Version 4.3.1. Unadjusted comparisons between cohorts were performed with a Kruskal Wallis test or Wilcoxon Rank-Sum test for continuous variables and a Chi-Square test or Fisher Exact test for categorical variables.</p><p id="Par17">To derive a radiographic phenotype of DRCB using PRM metrics that accounted for potential confounders (including BMI, age, gender, and smoking status) we first fit a linear regression model in the Control cohort to obtain log-transformed PRM variables using BMI, age, gender, and smoking status (binary indicating ever smoker) as predictors. Using these fitted models (one for each PRM variable), we predicted the PRM values for each member of the three cohorts. We calculated the adjusted PRM values by subtracting the predicted PRM from the observed PRM values. The adjusted PRM variables represented the amount by which the PRM is elevated with respect to Control for a subject&#x02019;s covariate profile. We then used the adjusted PRM variables to build a logistic regression model using logit link function <xref ref-type="bibr" rid="CR31">31</xref> in the Control and DRCB cohorts. Cohort assignment was the dependent variable and adjusted HAA, adjusted fSAD, and their interaction were the independent variables. We constructed a receiver-operating characteristics (ROC) curve from this model and calculated the area under the curve (AUC). Finally, we applied the logistic regression model to the adjusted PRM variables of the FDSV cohort. We calculated a probability index of being DRCB (DRCB-PI) for each member of the FDSV cohort based on their adjusted PRM. To create binary sub cohorts for statistical analysis, we grouped the FDSV cohort into two groups: DRCB-PI&#x02009;&#x0003e;&#x02009;0.5 (<italic>n</italic>&#x02009;=&#x02009;10) and &#x02264;&#x02009;0.5 (<italic>n</italic>&#x02009;=&#x02009;61). We compared phenotypic metrics between the two groups using Fisher&#x02019;s exact test for categorical variables or Wilcoxon rank sum test for continuous variables.</p></sec></sec><sec id="Sec7"><title>Results</title><sec id="Sec8"><title>Characteristics of the study populations</title><p id="Par18">Baseline demographics and lung function for all cohorts are reported in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>. Overall, FDSV subjects were significantly older than DRCB (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) and Control (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) subjects. Similarities in median BMI and proportion of males were seen in the FDSV subjects when compared to DRCB subjects but found to be statistically higher than Control subjects (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001 and <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001, respectively). The percentage of subjects who ever smoked were comparable between FDSV and DRCB subjects, yet less than Control subjects. The median pack years smoked for all FDSV subjects was comparable to Control subjects; this data was not available for the DRCB subjects. Median spirometry and lung volume measurements in all three cohorts did not identify obstructive or restrictive lung abnormalities. Despite all cohorts demonstrating no spirometric evidence of airflow limitation (FEV1/FVC&#x02009;&#x0003e;&#x02009;0.7 as defined by GOLD), FDSV and DRCB subjects had significantly lower values of FEV1% predicted (pp) than Control subjects. The FDSV subjects did show significantly lower TLCpp values than observed from DRCB (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) and Control subjects (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001). With respect to RV/TLC, a spirometric measure of air trapping, the ratio for FDSV subjects was similar to Control subjects and significantly lower than DRCB subjects (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01). No differences in DLCOpp were observed between cohorts.</p><p id="Par19">
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Study cohorts&#x02019; demographics and pulmonary function test results</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">DRCB</th><th align="left">FDSV</th><th align="left">Control</th><th align="left">
<italic>p</italic>
</th></tr></thead><tbody><tr><td align="left">
<bold>N</bold>
</td><td align="left">37</td><td align="left">71</td><td align="left">98</td><td align="left"/></tr><tr><td align="left">
<bold>Age (yrs)</bold>
</td><td align="left">35 (30, 39)</td><td align="left">45 (37, 52)</td><td align="left">40 (22, 53)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">
<bold>Sex (Male)</bold>
</td><td align="left">34 (92%)</td><td align="left">61 (86%)</td><td align="left">55 (56%)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">
<bold>BMI (Kg/m</bold>
<sup><bold>2</bold></sup>
<bold>)</bold>
</td><td align="left">29.9 (28.4, 31.9)</td><td align="left">31.7 (29.1, 36.0)</td><td align="left">23.5 (21.4, 25.5)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">
<bold>Ever-smoker (Y)</bold>
</td><td align="left">13 (35%)</td><td align="left">30 (42%)</td><td align="left">55 (56%)</td><td char="." align="char">0.05</td></tr><tr><td align="left">
<bold>Pack Years (yrs)</bold>
</td><td align="left">-*</td><td align="left">0 (0, 7)</td><td align="left">1 (0, 16)</td><td char="." align="char">0.05</td></tr><tr><td align="left">
<bold>FEV1pp (%)</bold>
</td><td align="left">98 (86, 103)</td><td align="left">95 (83, 107)</td><td align="left">108 (101, 114)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">
<bold>FEV1/FVC (%)</bold>
</td><td align="left">81 (75, 85)</td><td align="left">78 (75, 82)</td><td align="left">79 (74, 83)</td><td char="." align="char">0.2</td></tr><tr><td align="left">
<bold>TLCpp (%)</bold>
</td><td align="left">100 (93, 107)</td><td align="left">88 (80, 97)</td><td align="left">105 (99, 108)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">
<bold>RV/TLC (%)</bold>
</td><td align="left">30 (26, 33)</td><td align="left">25 (19, 30)</td><td align="left">26 (23, 31)</td><td char="." align="char">0.005</td></tr><tr><td align="left">
<bold>DLCOpp (%)</bold>
</td><td align="left">95 (87, 101)</td><td align="left">89 (78, 99)</td><td align="left">90 (83, 99)</td><td char="." align="char">0.13</td></tr></tbody></table><table-wrap-foot><p>* Cohort missing adequate numerical measurements</p><p>Data are shown as median (lower quartile, upper quartile), or N (%)</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec9"><title>Comparison of QCT metrics using parametric response mapping</title><p id="Par20">A comparison of unadjusted PRM metrics between cohorts (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>) revealed that the median %PRM<sup>Norm</sup> in the FDSV subjects was lower than that of the DRCB (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) and Control (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) subjects. The median %PRM<sup>fSAD</sup> in the FDSV subjects was significantly less than the DRCB subjects (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) but higher than Control subjects (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01) The median values of %PRM<sup>HAA</sup> were comparable between FDSV and DRCB subjects and elevated relative to Control subjects. The median %PRM<sup>Emph</sup> in the FDSV subjects was generally low yet increased relative to Control subjects (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01) and DRCB subjects (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001).</p><p id="Par21">
<fig id="Fig1"><label>Fig. 1</label><caption><p>PRM metrics of DRCB, FDSV, and control subjects. The unadjusted analyses compared relative lung parenchymal volume involved in all 4 PRM metrics including normal (%PRM<sup>Norm</sup>), functional small airways disease (%PRM<sup>fSAD</sup>), high attenuation area (%PRM<sup>HAA</sup>), and emphysema (%PRM<sup>Emph</sup>). In the box plot, the horizontal line within the box represents the median and the top and bottom represent the upper and lower quartiles. The whiskers represent 1.5 times the interquartile range. Points outside the box and whiskers represent outliers. * = <italic>p</italic>&#x02009;&#x02264;&#x02009;0.05, ** = <italic>p</italic>&#x02009;&#x02264;&#x02009;0.01 and *** = <italic>p</italic>&#x02009;&#x02264;&#x02009;0.001 by Wilcoxon Sum Rank test</p></caption><graphic xlink:href="12931_2025_3269_Fig1_HTML" id="d33e937"/></fig>
</p><p id="Par22">To further compare these cohorts, a principal component analysis (PCA) was performed using all four PRM metrics, age, gender, BMI, and ever smoking status. Results demonstrate that variance in the first principal component is attributable primarily to differences in %PRM<sup>Norm</sup> (<inline-formula id="IEq1"><alternatives><tex-math id="d33e943">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\:\iota\:$$\end{document}</tex-math><inline-graphic xlink:href="12931_2025_3269_Article_IEq1.gif"/></alternatives></inline-formula> = 0.54) with competing metrics being age (<inline-formula id="IEq2"><alternatives><tex-math id="d33e949">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\:\iota\:$$\end{document}</tex-math><inline-graphic xlink:href="12931_2025_3269_Article_IEq1.gif"/></alternatives></inline-formula> = -0.37), BMI (<inline-formula id="IEq3"><alternatives><tex-math id="d33e955">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\:\iota\:$$\end{document}</tex-math><inline-graphic xlink:href="12931_2025_3269_Article_IEq1.gif"/></alternatives></inline-formula> = -0.34), and gender (<inline-formula id="IEq4"><alternatives><tex-math id="d33e961">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\:\iota\:$$\end{document}</tex-math><inline-graphic xlink:href="12931_2025_3269_Article_IEq1.gif"/></alternatives></inline-formula> = -0.39), where <inline-formula id="IEq5"><alternatives><tex-math id="d33e968">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\:\iota\:$$\end{document}</tex-math><inline-graphic xlink:href="12931_2025_3269_Article_IEq1.gif"/></alternatives></inline-formula> is the loading coefficient. %PRM<sup>fSAD</sup> (<inline-formula id="IEq6"><alternatives><tex-math id="d33e976">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\:\iota\:$$\end{document}</tex-math><inline-graphic xlink:href="12931_2025_3269_Article_IEq1.gif"/></alternatives></inline-formula> = 0.46), %PRM<sup>Emph</sup> (<inline-formula id="IEq7"><alternatives><tex-math id="d33e984">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\:\iota\:$$\end{document}</tex-math><inline-graphic xlink:href="12931_2025_3269_Article_IEq1.gif"/></alternatives></inline-formula> = 0.54), and %PRM<sup>HAA</sup> (<inline-formula id="IEq8"><alternatives><tex-math id="d33e993">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\:\iota\:$$\end{document}</tex-math><inline-graphic xlink:href="12931_2025_3269_Article_IEq1.gif"/></alternatives></inline-formula> = -0.57) contributed primarily to variance in the second principal component. Ever Smoking status was a minor factor in both cases. The resultant PCA plot (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>) shows that the FDSV subjects have a composite PRM phenotype that overlaps more closely with DRCB subjects relative to Control subjects.</p><p id="Par23">
<fig id="Fig2"><label>Fig. 2</label><caption><p>The PCA comparison between cohorts performed using all 4 PRM metrics and age, gender, BMI, and smoking status (ever/never). Error ellipses are plotted for each group with 60% confidence, and vectors are plotted from the origin using the loadings of the first and second principal component for the labelled features</p></caption><graphic xlink:href="12931_2025_3269_Fig2_HTML" id="d33e1010"/></fig>
</p></sec><sec id="Sec10"><title>Derivation and assessment of a QCT-Based radiographic phenotype of DRCB</title><p id="Par24">To further assess FDSV subjects, a QCT-based radiographic phenotype of DRCB was derived using DRCB and Control subjects and used to create a DRCB-Probability Index (DRCB-PI). The model was created using demographic and adjusted PRM values obtained from DRCB and Control cohorts and captures the non-linear relationship between all adjusted PRM metrics to generate a probability value for each case ranging from 0 (least like DRCB) to 1 (most like DRCB). The findings of the model are displayed on a plot of adjusted PRM<sup>fSAD</sup> and PRM<sup>HAA</sup> as these metrics were strong determinants of overlap between DRCB and FDSV cohorts in our PCA (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). This model achieved an area under the curve value of 0.91 in performance to delineate biopsy-proven DRCB from asymptomatic cases (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>A). Applying this model to our FDSV cohort (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>B) reveals subjects displaying an array of adjusted PRM<sup>fSAD</sup> and PRM<sup>HAA</sup> values. Applying a cutoff of &#x0003e;&#x02009;0.5, we identified 10 out of 71 FDSV subjects as having a PRM phenotype that most resembled the biopsy-proven DRCB cohort (DRCB-PI&#x02009;&#x0003e;&#x02009;0.5). Provided in Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref> are two representative cases with low and high DRCB-PI. The case with a low DRCB-PI (of 0.05) is a 34-yr old female with moderate exposure to burn pit smoke during deployment. Values for PRM<sup>fSAD</sup> (3%) and PRM<sup>HAA</sup> (5%) were both low. In contrast, the case with a high DRCB-PI (of 0.93) is a 44-yr old male with severe exposure to burn pit smoke and values for PRM<sup>fSAD</sup> (12%) and PRM<sup>HAA</sup> (38%) were both high. Both cases were found to have normal values in FEV1 and FEV1/FVC.</p><p id="Par25">
<fig id="Fig3"><label>Fig. 3</label><caption><p>Identification of subjects with a radiographic phenotype of DRCB. (<bold>A</bold>) The area under the curve (AUC) plot derived from the model used to develop the DRCB-PI as an assessment tool for the identification of subjects with a radiographic phenotype of DRCB. (<bold>B</bold>) The application of the DRCB-PI to a cohort of 71 FDSV subjects (open circles) identifies 10 subjects with a DRCB-PI&#x02009;&#x0003e;&#x02009;0.50 (dashed line). Colors indicate the probability of DRCB from 0 (dark blue) to 1 (dark red)</p></caption><graphic xlink:href="12931_2025_3269_Fig3_HTML" id="d33e1061"/></fig>
</p><p id="Par26">
<fig id="Fig4"><label>Fig. 4</label><caption><p>Representative HRCT images from FDSV subjects. Inspiratory (left panels), expiratory (middle panels), and PRM (right panels) images from FDSV subjects with a DRCB-PI&#x02009;&#x0003c;&#x02009;0.5 (top row) and a DRCB-PI&#x02009;&#x0003e;&#x02009;0.5 (bottom row). PRM images are color coded to identify lung tissue as normal (green), functional small airways disease (yellow), high attenuation area (pink), and emphysema (red). Percentages of PRM<sup>fSAD</sup> (yellow text) and PRM<sup>HAA</sup> (red text) are provided for additional context</p></caption><graphic xlink:href="12931_2025_3269_Fig4_HTML" id="d33e1076"/></fig>
</p><p id="Par27">Having established a means of distinguishing FDSV subject by QCT, we next sought to assess whether these subjects with a high DRCB-PI differed from those with a low DRCB-PI using other parameters. Comparisons between FDSV subjects with a DRCB-PI&#x02009;&#x0003e;&#x02009;0.5 (<italic>n</italic>&#x02009;=&#x02009;10) versus DRCB-PI&#x02009;&#x02264;&#x02009;0.5 (<italic>n</italic>&#x02009;=&#x02009;61) revealed similar demographics and traditional lung function measurements including spirometry, lung volumes, and gas exchange (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). Respiratory oscillometry, however, differed between groups such that subjects with a DRCB-PI&#x02009;&#x0003e;&#x02009;0.5 demonstrated greater frequency dependence of resistance (R5-R20; <italic>P</italic>&#x02009;=&#x02009;0.001) and reactance area (AX; <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01). Total resistance (R5; <italic>p</italic>&#x02009;=&#x02009;0.055) and reactance (X5; <italic>p</italic>&#x02009;=&#x02009;0.20) were also increased in subjects with DRCB-PI&#x02009;&#x0003e;&#x02009;0.5, albeit non-significant. A DRCB-PI&#x02009;&#x0003e;&#x02009;0.5 was also associated with airway wall thickening (elevated Pi10; <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) and impaired total lung ventilation (Jacobian Mean closer to 1.0; <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) in addition to the expected differences in PRM metrics (i.e. lower PRM<sup>NORM</sup> and higher PRM<sup>fSAD</sup> and PRM<sup>HAA</sup>) resultant from the model used to generate the DRCB-PI.</p><p id="Par28">
<table-wrap id="Tab3"><label>Table 3</label><caption><p>Stratification of demographic, pulmonary function, and QCT metrics in FDSV subjects by DRCB probability index (DRCB-PI)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">DRCB-PI&#x02009;&#x02264;&#x02009;0.5</th><th align="left">DRCB-PI&#x02009;&#x0003e;&#x02009;0.5</th><th align="left">
<italic>p</italic>
</th></tr></thead><tbody><tr><td align="left">
<bold>N</bold>
</td><td align="left">61</td><td align="left">10</td><td align="left"/></tr><tr><td align="left">
<bold>Age (yrs)</bold>
</td><td align="left">45 (36, 52)</td><td align="left">48 (39, 54)</td><td char="." align="char">0.5</td></tr><tr><td align="left">
<bold>Sex (Male)</bold>
</td><td align="left">51 (84%)</td><td align="left">10 (100%)</td><td char="." align="char">0.3</td></tr><tr><td align="left">
<bold>BMI (Kg/m</bold>
<sup><bold>2</bold></sup>
<bold>)</bold>
</td><td align="left">31.7 (29.1, 36.2)</td><td align="left">32.5 (30.1, 35.0)</td><td char="." align="char">&#x0003e;&#x02009;0.9</td></tr><tr><td align="left">
<bold>Ever-smoker (Y)</bold>
</td><td align="left">25 (41%)</td><td align="left">5 (50%)</td><td char="." align="char">0.7</td></tr><tr><td align="left">
<bold>Pack Years (yrs)</bold>
</td><td align="left">0 (0, 6)</td><td align="left">2 (0, 7)</td><td char="." align="char">0.4</td></tr><tr><td align="left">Unavailable</td><td align="left">2</td><td align="left">0</td><td align="left"/></tr><tr><td align="left">
<bold>FEV1pp (%)</bold>
</td><td align="left">96 (84, 108)</td><td align="left">92 (74, 96)</td><td char="." align="char">0.3</td></tr><tr><td align="left">Unavailable</td><td align="left">2</td><td align="left">2</td><td align="left"/></tr><tr><td align="left">
<bold>FEV1/FVC (%)</bold>
</td><td align="left">78 (75, 82)</td><td align="left">78 (64, 81)</td><td char="." align="char">0.5</td></tr><tr><td align="left">Unavailable</td><td align="left">2</td><td align="left">2</td><td align="left"/></tr><tr><td align="left">
<bold>TLCpp (%)</bold>
</td><td align="left">88 (80, 97)</td><td align="left">92 (79, 101)</td><td char="." align="char">0.7</td></tr><tr><td align="left">Unavailable</td><td align="left">3</td><td align="left">2</td><td align="left"/></tr><tr><td align="left">
<bold>RV/TLC (%)</bold>
</td><td align="left">23 (19, 30)</td><td align="left">26 (15, 42)</td><td char="." align="char">0.6</td></tr><tr><td align="left">Unavailable</td><td align="left">3</td><td align="left">2</td><td align="left"/></tr><tr><td align="left">
<bold>DLCOpp (%)</bold>
</td><td align="left">89 (79, 96)</td><td align="left">85 (75, 102)</td><td char="." align="char">0.8</td></tr><tr><td align="left">Unavailable</td><td align="left">4</td><td align="left">2</td><td align="left"/></tr><tr><td align="left">
<bold>R5 (pp)</bold>
</td><td align="left">98 (75, 133)</td><td align="left">162 (112, 223)</td><td char="." align="char">0.055</td></tr><tr><td align="left">Unavailable</td><td align="left">22</td><td align="left">2</td><td align="left"/></tr><tr><td align="left">
<bold>X5 (pp)</bold>
</td><td align="left">95 (49, 131)</td><td align="left">153 (79, 391)</td><td char="." align="char">0.2</td></tr><tr><td align="left">Unavailable</td><td align="left">22</td><td align="left">2</td><td align="left"/></tr><tr><td align="left">
<bold>R5-R20 (kPa/L/s)</bold>
</td><td align="left">0.41 (-0.01, 0.91)</td><td align="left">2.17 (1.26, 3.50)</td><td char="." align="char">0.001</td></tr><tr><td align="left">Unavailable</td><td align="left">22</td><td align="left">2</td><td align="left"/></tr><tr><td align="left">
<bold>AX (kPa/L)</bold>
</td><td align="left">9 (4, 17)</td><td align="left">35 (26, 64)</td><td char="." align="char">0.002</td></tr><tr><td align="left">Unavailable</td><td align="left">22</td><td align="left">2</td><td align="left"/></tr><tr><td align="left">
<bold>Wall Area (%)</bold>
</td><td align="left">45.8 (41.0, 48.4)</td><td align="left">49.6 (46.7, 51.3)</td><td char="." align="char">0.12</td></tr><tr><td align="left">Unavailable</td><td align="left">8</td><td align="left">2</td><td align="left"/></tr><tr><td align="left">
<bold>Pi10 (cm)</bold>
</td><td align="left">0.19 (0.14, 0.23)</td><td align="left">0.29 (0.22, 0.31)</td><td char="." align="char">0.023</td></tr><tr><td align="left">Unavailable</td><td align="left">8</td><td align="left">2</td><td align="left"/></tr><tr><td align="left">
<bold>Jac Mean</bold>
</td><td align="left">1.73 (1.59, 2.15)</td><td align="left">1.35 (1.24, 1.46)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">Unavailable</td><td align="left">8</td><td align="left">2</td><td align="left"/></tr><tr><td align="left">
<bold>PRM</bold>
<sup><bold>Norm</bold></sup>
</td><td align="left">54 (46, 65)</td><td align="left">36 (27, 39)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">
<bold>PRM</bold>
<sup><bold>fSAD</bold></sup>
</td><td align="left">5.0 (2.2, 7.8)</td><td align="left">11.5 (8.1, 12.0)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">
<bold>PRM</bold>
<sup><bold>HAA</bold></sup>
</td><td align="left">17 (8, 27)</td><td align="left">29 (27, 46)</td><td char="." align="char">0.005</td></tr><tr><td align="left">
<bold>PRM</bold>
<sup><bold>Emph</bold></sup>
</td><td align="left">1.07 (0.06, 2.02)</td><td align="left">1.79 (1.16, 2.20)</td><td char="." align="char">0.2</td></tr></tbody></table><table-wrap-foot><p>Data are shown as median (lower quartile, upper quartile), or N (%)</p></table-wrap-foot></table-wrap>
</p><p id="Par29">Lastly, the DRCB-PI was used to assess whether the QCT-derived DRCB phenotype distinguished FDSV subjects based on symptoms or self-reported health effects from deployment exposures (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>). Symptoms of cough, wheeze and SOB were common in all FDSV subjects yet increased in FDSV subjects with a DRCB-PI&#x02009;&#x0003e;&#x02009;0.5 (relative to those with a DRCB-PI&#x02009;&#x02264;&#x02009;0.5) although these findings did not reach statistical significance. Exposures to burn pit smoke, sand and dust, and petrochemicals were common in all FDSV subjects. Yet subjects with a DRCB-PI&#x02009;&#x0003e;&#x02009;0.5 self-reported more severe health effects from exposures to burn pit smoke (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) and sand and dust (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) and a non-significant increase in severe petrochemical exposure (<italic>P</italic>&#x02009;=&#x02009;0.063).</p><p id="Par30">
<table-wrap id="Tab4"><label>Table 4</label><caption><p>Stratification of symptom and exposure metrics in FDSV subjects by DRCB probability index (DRCB-PI)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">DRCB-PI&#x02009;&#x02264;&#x02009;0.5</th><th align="left">DRCB-PI&#x02009;&#x0003e;&#x02009;0.5</th><th align="left">
<italic>p</italic>
</th></tr></thead><tbody><tr><td align="left">
<bold>N</bold>
</td><td align="left">61</td><td align="left">10</td><td align="left"/></tr><tr><td align="left">
<bold>Cough</bold>
</td><td align="left">29 (57%)</td><td align="left">8 (80%)</td><td char="." align="char">0.3</td></tr><tr><td align="left">Unavailable</td><td align="left">10</td><td align="left">0</td><td align="left"/></tr><tr><td align="left">
<bold>Wheeze</bold>
</td><td align="left">29 (59%)</td><td align="left">8 (80%)</td><td char="." align="char">0.3</td></tr><tr><td align="left">Unavailable</td><td align="left">12</td><td align="left">0</td><td align="left"/></tr><tr><td align="left">
<bold>SOB</bold>
</td><td align="left">44 (81%)</td><td align="left">9 (90%)</td><td char="." align="char">&#x0003e;&#x02009;0.9</td></tr><tr><td align="left">Unavailable</td><td align="left">7</td><td align="left">0</td><td align="left"/></tr><tr><td align="left">
<bold>Burn Pit Smoke</bold>
</td><td align="left"/><td align="left"/><td char="." align="char">0.028</td></tr><tr><td align="left">Mild/None</td><td align="left">9 (18%)</td><td align="left">1 (11%)</td><td align="left"/></tr><tr><td align="left">Moderate</td><td align="left">29 (59%)</td><td align="left">2 (22%)</td><td align="left"/></tr><tr><td align="left">Severe</td><td align="left">11 (22%)</td><td align="left">6 (67%)</td><td align="left"/></tr><tr><td align="left">Unavailable</td><td align="left">12</td><td align="left">1</td><td align="left"/></tr><tr><td align="left">
<bold>Sand and dust</bold>
</td><td align="left"/><td align="left"/><td char="." align="char">0.041</td></tr><tr><td align="left">Mild/None</td><td align="left">10 (19%)</td><td align="left">1 (10%)</td><td align="left"/></tr><tr><td align="left">Moderate</td><td align="left">29 (54%)</td><td align="left">2 (20%)</td><td align="left"/></tr><tr><td align="left">Severe</td><td align="left">15 (28%)</td><td align="left">7 (70%)</td><td align="left"/></tr><tr><td align="left">Unavailable</td><td align="left">7</td><td align="left">0</td><td align="left"/></tr><tr><td align="left">
<bold>Petrochemicals</bold>
</td><td align="left"/><td align="left"/><td char="." align="char">0.063</td></tr><tr><td align="left">Mild/None</td><td align="left">20 (40%)</td><td align="left">3 (43%)</td><td align="left"/></tr><tr><td align="left">Moderate</td><td align="left">24 (48%)</td><td align="left">1 (14%)</td><td align="left"/></tr><tr><td align="left">Severe</td><td align="left">6 (12%)</td><td align="left">3 (43%)</td><td align="left"/></tr><tr><td align="left">Unavailable</td><td align="left">11</td><td align="left">3</td><td align="left"/></tr></tbody></table><table-wrap-foot><p>Data are shown as N (%). SOB is shortness of breath</p></table-wrap-foot></table-wrap>
</p></sec></sec><sec id="Sec11"><title>Discussion</title><p id="Par31">The current study responded to two prominent challenges that have limited our understanding of DRCB and additional forms of chronic lung injury that may exist in a subset of individuals formerly deployed to post 9/11 conflicts in Iraq and Afghanistan. First, non-invasive tests including conventional pulmonary function tests and clinical interpretations of HRCT scans are insensitive for DRCB detection <xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR12">12</xref>. Second, concerns about the risks and benefits of performing surgical lung biopsy limit the ability to evaluate new testing approaches in patients with biopsy-confirmed disease. We responded to these challenges by deriving a QCT-based radiographic phenotype of DRCB using HRCT obtained in military personnel with biopsy-proven DRCB and used this phenotype to augment our assessment of non-biopsied veterans. Our findings demonstrated that FDSV with the DRCB phenotype (DRCB-PI&#x02009;&#x0003e;&#x02009;0.5) have greater abnormalities on oscillometry, increased airway wall thickness and greater impairments in total lung ventilation (detected by QCT), despite similar pulmonary function on conventional assessments relative to subjects with a DRCB-PI&#x02009;&#x02264;&#x02009;0.5. These subjects also self-reported more intense health effects at the time of their exposure to military burn pit smoke and sand and dust storms. Collectively, our results show the potential for a QCT-derived radiographic phenotype of DRCB to improve non-invasive assessments of FDSV.</p><p id="Par32">We previously showed that HRCT obtained on military personnel at the time they underwent surgical lung biopsy are amendable to QCT analysis using parametric response mapping <xref ref-type="bibr" rid="CR18">18</xref>. Results demonstrated that the amount of %PRM<sup>fSAD</sup> present in military personnel with biopsy-proven DRCB is increased relative to asymptomatic controls and patients with mild to moderate COPD <xref ref-type="bibr" rid="CR18">18</xref>. In the current study, we found that the median %PRM<sup>fSAD</sup> was also increased in the FDSV cohort. Yet completion of a more comprehensive PRM-based assessment revealed considerable heterogeneity in the amount of PRM<sup>Norm</sup>, PRM<sup>fSAD</sup>, PRM<sup>HAA</sup>, and PRM<sup>Emph</sup> in both the DRCB and FDSV cohorts. We believe PRM heterogeneity may reflect the varying forms of chronic lung injury, including but not limited to DRCB, reported in multiple studies <xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR32">32</xref>. This degree of observed PRM heterogeneity suggests that development of a QCT-based approach to DRCB phenotyping should not rely on a single PRM metric such as fSAD. Rather it motivated development of a composite PRM-based phenotype that accounted for all 4 PRM metrics and potentially confounding demographic variables. Thus, we derived the DRCB-PI as a composite metric to convey the degree to which a HRCT was similar to the QCT-derived DRCB phenotype.</p><p id="Par33">Application of the DRCB-PI to the FDSV cohort yielded a spectrum of patients along the DRCB-PI continuum. Due to limited sample size, as a proof of concept a binary threshold of &#x0003e;&#x02009;0.5 was chosen to identify the FDSV subjects whose QCT-derived radiographic phenotype was most comparable to subjects with DRCB. We found that the DRCB-PI did not differentiate FDSV subjects on the basis of conventional pulmonary function tests. In contrast, we found that FDSV subjects with a DRCB-PI&#x02009;&#x0003e;&#x02009;0.5 had more abnormal oscillometry including increases in reactance area and frequency dependence of resistance (R5-R20), with additional non-significant increases in total resistance and reactance. This pattern of findings is suggestive of small airways disease. These findings extend those of Butzko and colleagues who had previously shown that 75% of FDSV subjects with preserved spirometry had one or more FOT abnormalities <xref ref-type="bibr" rid="CR27">27</xref>. Similarly, a study by Hines and colleagues had previously shown that airflow obstruction was more readily detected by impulse oscillometry relative to spirometry in assessment of Gulf War veterans <xref ref-type="bibr" rid="CR33">33</xref>. Thus, our analysis adds to the mounting evidence that conventional PFTs can be normal despite histopathologic and radiographic evidence of DRCB and suggest that oscillometry might prove more informative, particularly among those with environmental and occupational exposure [see Kaminsky et al. 2022 for review <xref ref-type="bibr" rid="CR34">34</xref>].</p><p id="Par34">Additional QCT data revealed that FDSV subjects with a DRCB-PI&#x02009;&#x0003e;&#x02009;0.5 had increases in Pi10 (an indicator of airway wall thickness), reductions in Jacobian Mean Ventilation (an indication of impaired total lung ventilation), and a trend towards increased emphysema (by %PRM<sup>Emph</sup>). These findings are compatible with a study by Zell-Baron and colleagues <xref ref-type="bibr" rid="CR35">35</xref> which identified an increase in Pi10 and a quantitative CT metric for emphysema in their analysis of CT scans obtained from subjects they defined as having deployment-related distal lung disease. In contrast to our findings, their study did not identify quantitative CT evidence of increased air trapping. A direct comparison of our findings with these studies is limited by differences in both the deployed and control cohorts and the technique used to quantify air trapping.</p><p id="Par35">The inability to reliably identify DRCB non-invasively have hindered prior efforts to understand symptoms and exposures associated with the disorder. In this study, application of the DRCB-PI to a subset of FDSV subjects that completed symptoms and exposure questionnaires revealed that FDSV subjects whose DRCB-PI was &#x0003e;&#x02009;0.5 experienced more severe self-reported health effects immediately following exposures to burn pit smoke and sand and dust. The data further showed that FDSV subjects with a DRCB-PI&#x02009;&#x0003e;&#x02009;0.5 also reported greater exposure to petrochemicals and symptoms of cough and wheeze, albeit non-significant. These findings bolster a recent report linking chronic respiratory symptoms with military exposures to burn pits and vapors, gasses, dusts and fumes <xref ref-type="bibr" rid="CR5">5</xref> and suggest that a QCT-derived phenotype of DRCB may aid future efforts seeking to identify the cause(s) of DRCB.</p><sec id="Sec12"><title>Limitations</title><p id="Par36">HRCT scans from the DRCB and FDSV cohorts were obtained for clinical purposes and were not prospectively acquired using a standardized protocol. Thus, although our PRM analysis accounts for differences in scan acquisition <xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>, differences in scanner, scan protocol, and exhalation volumes might still have impacted PRM measurements. In addition, our assessment of subjects with biopsy-proven DRCB was limited to subjects with histopathologic evidence of CB. It&#x02019;s unknown whether additional interstitial, airspace, or vascular abnormalities were present, as has been reported in some subjects. <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR35">35</xref>. Data pertaining to inhalational hazards relied on self-reported exposures subject to recall bias. Also, there is a paucity of large well-characterized cohorts of asymptomatic or formerly-deployed symptomatic subjects that have undergone HRCT imaging. As such, small sample sizes may have limited our ability to identify additional significant associations between the DRCB-PI and other phenotypic metrics. Lastly, our subjects were assessed at specialty referral centers and our findings may not be generalizable to veterans evaluated at local health care facilities.</p></sec></sec><sec id="Sec13"><title>Conclusions</title><p id="Par37">In this study we show that a QCT-derived radiographic phenotype of DRCB identified a subset of formerly deployed symptomatic veterans with abnormal oscillometry and more severe self-reported health effects following inhalational exposures to burn pit smoke and sand and dust storms during military deployment. Further efforts are warranted to incorporate QCT-based phenotyping into non-invasive strategies to detect constrictive bronchiolitis and other forms of chronic lung injury.</p></sec><sec id="Sec14" sec-type="supplementary-material"><title>Electronic supplementary material</title><p>Below is the link to the electronic supplementary material.</p><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="12931_2025_3269_MOESM1_ESM.docx"><caption><p>Supplementary Material 1</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p>
<bold>Prior presentations</bold>
</p><p>An abstract demonstrating preliminary results of this study was presented at the International Conference of the American Thoracic Society (May 2024, San Diego, CA).</p></fn><fn><p><bold>Publisher&#x02019;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>Authors want to acknowledge the Veterans who underwent clinical evaluation and were part of this study. In addition, we appreciate the support of the VA New Jersey Health Care Service&#x02019;s Imaging Service and our collaborators at the Airborne Hazards and Burn Pits Center of Excellence for procuring these data (Anays Sotolongo, MD; Wei Qian, MD; Thomas Alexander, MS; Bishoy Samy, MS). We also acknowledge Dr. Maarten van den Berge and his associates at the University of Groningen for allowing use of data they obtained as part of &#x0201c;A Study to Obtain Normal Values of Inflammatory Variables from Healthy Subjects&#x0201d;.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>AJB, MJF, CJG, and JJO conceived the study and hypotheses. AJB managed data preparation, statistical analysis, software implementation, experimentation, and presentation of results. AJB and JJO wrote the initial draft of the manuscript. MJF, CJG, and JJO supervised the project. SR, BWR, RFM, EAK, CRH, MKH, and EAK provided domain expert advice and evaluation of the project. MJF and GP provided data (FDSV cohort) and assisted with data analysis. BWR and RFM provided data (DRCB cohort) and assisted with data analysis. MM and GP assisted on the statistical analyses and modeling. All authors provided substantive, critical reviews and approved of the submitted manuscript. JJO is the guarantor of the content of the manuscript, including the data and analysis.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Department of Defense GW160154 and TX220104. Department of Veterans Affairs Merit Review Award (JJO).</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>No datasets were generated or analysed during the current study.</p></notes><notes><title>Declarations</title><notes id="FPar3"><title>Ethics approval and consent to participate</title><p id="Par38">The study was conducted in accordance with approvals obtained following IRB review at the following institutions: VA Ann Arbor Health System (1754681) the University of Michigan (HUM00246250) and the Vanderbilt Medical Center.</p></notes><notes id="FPar1"><title>Consent for publication</title><p id="Par39">Not applicable.</p></notes><notes id="FPar2" notes-type="COI-statement"><title>Competing interests</title><p id="Par40">Craig Galban reports a relationship with Imbio Inc that includes equity or stocks. Imbio Inc originally held the license of the parametric response mapping technology used in our analysis. Charles Hatt reports a relationship with 4D Medicine Ltd that includes employment. 4D Medicine Ltd now holds the license for the parametric response mapping technology used in our analysis.</p></notes></notes><glossary><title>Abbreviations</title><def-list><def-item><term>CB</term><def><p id="Par41">Constrictive bronchiolitis</p></def></def-item><def-item><term>CT</term><def><p id="Par42">Computed tomography</p></def></def-item><def-item><term>DRCB</term><def><p id="Par43">Deployment-related constrictive bronchiolitis</p></def></def-item><def-item><term>DRCB-PI</term><def><p id="Par44">Deployment related constrictive bronchiolitis probability index</p></def></def-item><def-item><term>FDSV</term><def><p id="Par45">Formerly-deployed symptomatic veterans</p></def></def-item><def-item><term>HRCT</term><def><p id="Par46">High resolution computed tomography</p></def></def-item><def-item><term>PCA</term><def><p id="Par47">Principal component analysis</p></def></def-item><def-item><term>PFT</term><def><p id="Par48">Pulmonary function test</p></def></def-item><def-item><term>PRM</term><def><p id="Par49">Parametric response mapping</p></def></def-item><def-item><term>PRM<sup>Emph</sup></term><def><p id="Par50">PRM-Emphysema</p></def></def-item><def-item><term>PRM<sup>fSAD</sup></term><def><p id="Par51">PRM-functional small airways disease</p></def></def-item><def-item><term>PRM<sup>HAA</sup></term><def><p id="Par52">PRM-high attenuation area</p></def></def-item><def-item><term>PRM<sup>Norm</sup></term><def><p id="Par53">PRM-Normal lung</p></def></def-item><def-item><term>QCT</term><def><p id="Par54">Quantitative computed tomography</p></def></def-item></def-list></glossary><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="book"><person-group person-group-type="editor"><collab>Respiratory health effects</collab><name><surname>Press</surname></name><name><surname>NAoSEaM</surname></name></person-group><source>Of airborne hazards exposures in the Southwest Asia theater of military operations</source><year>2020</year><publisher-loc>Washington, DC</publisher-loc><publisher-name>National Academies</publisher-name></element-citation><mixed-citation id="mc-CR1" publication-type="book">Respiratory health effects. In: Press, NAoSEaM, editors. Of airborne hazards exposures in the Southwest Asia theater of military operations. Washington, DC:: National Academies; 2020.</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="book"><person-group person-group-type="author"><collab>National Academies of Sciences E</collab><name><surname>Medicine</surname></name></person-group><source>Reassessment of the department of veterans affairs airborne hazards and open burn pit registry</source><year>2022</year><publisher-loc>Washington, DC</publisher-loc><publisher-name>National Academies</publisher-name></element-citation><mixed-citation id="mc-CR2" publication-type="book">National Academies of Sciences E, Medicine. Reassessment of the department of veterans affairs airborne hazards and open burn pit registry. Washington, DC: National Academies; 2022.</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Garshick</surname><given-names>E</given-names></name><name><surname>Blanc</surname><given-names>PD</given-names></name></person-group><article-title>Military deployment-related respiratory problems: an update</article-title><source>Curr Opin Pulm Med</source><year>2023</year><volume>29</volume><issue>2</issue><fpage>83</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1097/MCP.0000000000000946</pub-id><pub-id pub-id-type="pmid">36597757</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Garshick E, Blanc PD. Military deployment-related respiratory problems: an update. Curr Opin Pulm Med. 2023;29(2):83&#x02013;9.<pub-id pub-id-type="pmid">36597757</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Krefft</surname><given-names>SD</given-names></name><name><surname>Zell-Baran</surname><given-names>LM</given-names></name></person-group><article-title>Deployment-Related respiratory disease: where are we??</article-title><source>Semin Respir Crit Care Med</source><year>2023</year><volume>44</volume><issue>3</issue><fpage>370</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1055/s-0043-1764407</pub-id><pub-id pub-id-type="pmid">37068518</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Krefft SD, Zell-Baran LM. Deployment-Related respiratory disease: where are we?? Semin Respir Crit Care Med. 2023;44(3):370&#x02013;7.<pub-id pub-id-type="pmid">37068518</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Garshick</surname><given-names>E</given-names></name><name><surname>Redlich</surname><given-names>CA</given-names></name><name><surname>Korpak</surname><given-names>A</given-names></name><etal/></person-group><article-title>Chronic respiratory symptoms following deployment-related occupational and environmental exposures among US veterans</article-title><source>Occup Environ Med</source><year>2024</year><volume>81</volume><issue>2</issue><fpage>59</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1136/oemed-2023-109146</pub-id><pub-id pub-id-type="pmid">37968126</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Garshick E, Redlich CA, Korpak A, et al. Chronic respiratory symptoms following deployment-related occupational and environmental exposures among US veterans. Occup Environ Med. 2024;81(2):59&#x02013;65.<pub-id pub-id-type="pmid">37968126</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Savitz</surname><given-names>DA</given-names></name><name><surname>Woskie</surname><given-names>SR</given-names></name><name><surname>Bello</surname><given-names>A</given-names></name><etal/></person-group><article-title>Deployment to military bases with open burn pits and respiratory and cardiovascular disease</article-title><source>JAMA Netw Open</source><year>2024</year><volume>7</volume><issue>4</issue><fpage>e247629</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2024.7629</pub-id><pub-id pub-id-type="pmid">38662371</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Savitz DA, Woskie SR, Bello A, et al. Deployment to military bases with open burn pits and respiratory and cardiovascular disease. JAMA Netw Open. 2024;7(4):e247629.<pub-id pub-id-type="pmid">38662371</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>MJ</given-names></name><name><surname>Walter</surname><given-names>RJ</given-names></name><name><surname>McCann</surname><given-names>ET</given-names></name><etal/></person-group><article-title>Clinical evaluation of deployed military personnel with chronic respiratory symptoms: study of active duty military for pulmonary disease related to environmental deployment exposures (STAMPEDE) III</article-title><source>Chest</source><year>2020</year><volume>157</volume><issue>6</issue><fpage>1559</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/j.chest.2020.01.024</pub-id><pub-id pub-id-type="pmid">32017933</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Morris MJ, Walter RJ, McCann ET, et al. Clinical evaluation of deployed military personnel with chronic respiratory symptoms: study of active duty military for pulmonary disease related to environmental deployment exposures (STAMPEDE) III. Chest. 2020;157(6):1559&#x02013;67.<pub-id pub-id-type="pmid">32017933</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>MS</given-names></name><name><surname>Eisenberg</surname><given-names>R</given-names></name><name><surname>Newman</surname><given-names>JH</given-names></name><etal/></person-group><article-title>Constrictive bronchiolitis in soldiers returning from Iraq and Afghanistan</article-title><source>N Engl J Med</source><year>2011</year><volume>365</volume><issue>3</issue><fpage>222</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1101388</pub-id><pub-id pub-id-type="pmid">21774710</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">King MS, Eisenberg R, Newman JH, et al. Constrictive bronchiolitis in soldiers returning from Iraq and Afghanistan. N Engl J Med. 2011;365(3):222&#x02013;30.<pub-id pub-id-type="pmid">21774710</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Krefft</surname><given-names>SD</given-names></name><name><surname>Wolff</surname><given-names>J</given-names></name><name><surname>Zell-Baran</surname><given-names>L</given-names></name><etal/></person-group><article-title>Respiratory diseases in Post-9/11 military personnel following Southwest Asia deployment</article-title><source>J Occup Environ Med</source><year>2020</year><volume>62</volume><issue>5</issue><fpage>337</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1097/JOM.0000000000001817</pub-id><pub-id pub-id-type="pmid">31977922</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Krefft SD, Wolff J, Zell-Baran L, et al. Respiratory diseases in Post-9/11 military personnel following Southwest Asia deployment. J Occup Environ Med. 2020;62(5):337&#x02013;43.<pub-id pub-id-type="pmid">31977922</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Gutor</surname><given-names>SS</given-names></name><name><surname>Richmond</surname><given-names>BW</given-names></name><name><surname>Du</surname><given-names>RH</given-names></name><etal/></person-group><article-title>Postdeployment respiratory syndrome in soldiers with chronic exertional dyspnea</article-title><source>Am J Surg Pathol</source><year>2021</year><volume>45</volume><issue>12</issue><fpage>1587</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1097/PAS.0000000000001757</pub-id><pub-id pub-id-type="pmid">34081035</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Gutor SS, Richmond BW, Du RH, et al. Postdeployment respiratory syndrome in soldiers with chronic exertional dyspnea. Am J Surg Pathol. 2021;45(12):1587&#x02013;96.<pub-id pub-id-type="pmid">34081035</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Gutor</surname><given-names>SS</given-names></name><name><surname>Richmond</surname><given-names>BW</given-names></name><name><surname>Agrawal</surname><given-names>V</given-names></name><etal/></person-group><article-title>Pulmonary vascular disease in veterans with post-deployment respiratory syndrome</article-title><source>Cardiovasc Pathol</source><year>2024</year><volume>71</volume><fpage>107640</fpage><pub-id pub-id-type="doi">10.1016/j.carpath.2024.107640</pub-id><pub-id pub-id-type="pmid">38604505</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Gutor SS, Richmond BW, Agrawal V, et al. Pulmonary vascular disease in veterans with post-deployment respiratory syndrome. Cardiovasc Pathol. 2024;71:107640.<pub-id pub-id-type="pmid">38604505</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Falvo</surname><given-names>MJ</given-names></name><name><surname>Sotolongo</surname><given-names>AM</given-names></name><name><surname>Osterholzer</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>Consensus statements on Deployment-Related respiratory disease, inclusive of constrictive bronchiolitis: A modified Delphi study</article-title><source>Chest</source><year>2023</year><volume>163</volume><issue>3</issue><fpage>599</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1016/j.chest.2022.10.031</pub-id><pub-id pub-id-type="pmid">36343686</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Falvo MJ, Sotolongo AM, Osterholzer JJ, et al. Consensus statements on Deployment-Related respiratory disease, inclusive of constrictive bronchiolitis: A modified Delphi study. Chest. 2023;163(3):599&#x02013;609.<pub-id pub-id-type="pmid">36343686</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Galban</surname><given-names>CJ</given-names></name><name><surname>Han</surname><given-names>MK</given-names></name><name><surname>Boes</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression</article-title><source>Nat Med</source><year>2012</year><volume>18</volume><issue>11</issue><fpage>1711</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1038/nm.2971</pub-id><pub-id pub-id-type="pmid">23042237</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Galban CJ, Han MK, Boes JL, et al. Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med. 2012;18(11):1711&#x02013;5.<pub-id pub-id-type="pmid">23042237</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Galban</surname><given-names>CJ</given-names></name><name><surname>Boes</surname><given-names>JL</given-names></name><name><surname>Bule</surname><given-names>M</given-names></name><etal/></person-group><article-title>Parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation</article-title><source>Biol Blood Marrow Transpl</source><year>2014</year><volume>20</volume><issue>10</issue><fpage>1592</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.bbmt.2014.06.014</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Galban CJ, Boes JL, Bule M, et al. Parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2014;20(10):1592&#x02013;8.</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Verleden</surname><given-names>SE</given-names></name><name><surname>Vos</surname><given-names>R</given-names></name><name><surname>Vandermeulen</surname><given-names>E</given-names></name><etal/></person-group><article-title>Parametric response mapping of bronchiolitis obliterans syndrome progression after lung transplantation</article-title><source>Am J Transpl</source><year>2016</year><volume>16</volume><issue>11</issue><fpage>3262</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1111/ajt.13945</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Verleden SE, Vos R, Vandermeulen E, et al. Parametric response mapping of bronchiolitis obliterans syndrome progression after lung transplantation. Am J Transpl. 2016;16(11):3262&#x02013;9.</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Pompe</surname><given-names>E</given-names></name><name><surname>Galban</surname><given-names>CJ</given-names></name><name><surname>Ross</surname><given-names>BD</given-names></name><etal/></person-group><article-title>Parametric response mapping on chest computed tomography associates with clinical and functional parameters in chronic obstructive pulmonary disease</article-title><source>Respir Med</source><year>2017</year><volume>123</volume><fpage>48</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/j.rmed.2016.11.021</pub-id><pub-id pub-id-type="pmid">28137496</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Pompe E, Galban CJ, Ross BD, et al. Parametric response mapping on chest computed tomography associates with clinical and functional parameters in chronic obstructive pulmonary disease. Respir Med. 2017;123:48&#x02013;55.<pub-id pub-id-type="pmid">28137496</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Matrosic</surname><given-names>CK</given-names></name><name><surname>Owen</surname><given-names>DR</given-names></name><name><surname>Polan</surname><given-names>D</given-names></name><etal/></person-group><article-title>Feasibility of function-guided lung treatment planning with parametric response mapping</article-title><source>J Appl Clin Med Phys</source><year>2021</year><volume>22</volume><issue>11</issue><fpage>80</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1002/acm2.13436</pub-id><pub-id pub-id-type="pmid">34697884</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Matrosic CK, Owen DR, Polan D, et al. Feasibility of function-guided lung treatment planning with parametric response mapping. J Appl Clin Med Phys. 2021;22(11):80&#x02013;9.<pub-id pub-id-type="pmid">34697884</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>CW</given-names></name><name><surname>Lopez</surname><given-names>CL</given-names></name><name><surname>Bell</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>The severity of functional small airway disease in military personnel with constrictive bronchiolitis as measured by quantitative computed tomography</article-title><source>Am J Respir Crit Care Med</source><year>2022</year><volume>206</volume><issue>6</issue><fpage>786</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1164/rccm.202201-0153LE</pub-id><pub-id pub-id-type="pmid">35608541</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Davis CW, Lopez CL, Bell AJ, et al. The severity of functional small airway disease in military personnel with constrictive bronchiolitis as measured by quantitative computed tomography. Am J Respir Crit Care Med. 2022;206(6):786&#x02013;9.<pub-id pub-id-type="pmid">35608541</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Nair</surname><given-names>GB</given-names></name><name><surname>Galban</surname><given-names>CJ</given-names></name><name><surname>Al-Katib</surname><given-names>S</given-names></name><etal/></person-group><article-title>An assessment of the correlation between robust CT-derived ventilation and pulmonary function test in a cohort with no respiratory symptoms</article-title><source>Br J Radiol</source><year>2021</year><volume>94</volume><issue>1118</issue><fpage>20201218</fpage><pub-id pub-id-type="doi">10.1259/bjr.20201218</pub-id><pub-id pub-id-type="pmid">33320729</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Nair GB, Galban CJ, Al-Katib S, et al. An assessment of the correlation between robust CT-derived ventilation and pulmonary function test in a cohort with no respiratory symptoms. Br J Radiol. 2021;94(1118):20201218.<pub-id pub-id-type="pmid">33320729</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Culver</surname><given-names>BH</given-names></name><name><surname>Graham</surname><given-names>BL</given-names></name><name><surname>Coates</surname><given-names>AL</given-names></name><etal/></person-group><article-title>Recommendations for a standardized pulmonary function report. An official American thoracic society technical statement</article-title><source>Am J Respir Crit Care Med</source><year>2017</year><volume>196</volume><issue>11</issue><fpage>1463</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1164/rccm.201710-1981ST</pub-id><pub-id pub-id-type="pmid">29192835</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Culver BH, Graham BL, Coates AL, et al. Recommendations for a standardized pulmonary function report. An official American thoracic society technical statement. Am J Respir Crit Care Med. 2017;196(11):1463&#x02013;72.<pub-id pub-id-type="pmid">29192835</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="other">Graham BL, Brusasco V, Burgos F et al. 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung. Eur Respir J 2017;49(1).</mixed-citation></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Graham</surname><given-names>BL</given-names></name><name><surname>Steenbruggen</surname><given-names>I</given-names></name><name><surname>Miller</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Standardization of spirometry 2019 update. An official American thoracic society and European respiratory society technical statement</article-title><source>Am J Respir Crit Care Med</source><year>2019</year><volume>200</volume><issue>8</issue><fpage>e70</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1164/rccm.201908-1590ST</pub-id><pub-id pub-id-type="pmid">31613151</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Graham BL, Steenbruggen I, Miller MR, et al. Standardization of spirometry 2019 update. An official American thoracic society and European respiratory society technical statement. Am J Respir Crit Care Med. 2019;200(8):e70&#x02013;88.<pub-id pub-id-type="pmid">31613151</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="other">Hall GL, Filipow N, Ruppel G et al. Official ERS technical standard: global lung function initiative reference values for static lung volumes in individuals of European ancestry. Eur Respir J 2021;57(3).</mixed-citation></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Quanjer</surname><given-names>PH</given-names></name><name><surname>Stanojevic</surname><given-names>S</given-names></name><name><surname>Cole</surname><given-names>TJ</given-names></name><etal/></person-group><article-title>Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations</article-title><source>Eur Respir J</source><year>2012</year><volume>40</volume><issue>6</issue><fpage>1324</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1183/09031936.00080312</pub-id><pub-id pub-id-type="pmid">22743675</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324&#x02013;43.<pub-id pub-id-type="pmid">22743675</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="other">Stanojevic S, Graham BL, Cooper BG et al. Official ERS technical standards: global lung function initiative reference values for the carbon monoxide transfer factor for Caucasians. Eur Respir J 2017;50(3).</mixed-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="other">King GG, Bates J, Berger KI et al. Technical standards for respiratory oscillometry. Eur Respir J 2020;55(2).</mixed-citation></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Butzko</surname><given-names>RP</given-names></name><name><surname>Sotolongo</surname><given-names>AM</given-names></name><name><surname>Helmer</surname><given-names>DA</given-names></name><etal/></person-group><article-title>Forced Oscillation technique in veterans with preserved spirometry and chronic respiratory symptoms</article-title><source>Respir Physiol Neurobiol</source><year>2019</year><volume>260</volume><fpage>8</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1016/j.resp.2018.11.012</pub-id><pub-id pub-id-type="pmid">30508589</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Butzko RP, Sotolongo AM, Helmer DA, et al. Forced Oscillation technique in veterans with preserved spirometry and chronic respiratory symptoms. Respir Physiol Neurobiol. 2019;260:8&#x02013;16.<pub-id pub-id-type="pmid">30508589</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Belloli</surname><given-names>EA</given-names></name><name><surname>Degtiar</surname><given-names>I</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><etal/></person-group><article-title>Parametric response mapping as an imaging biomarker in lung transplant recipients</article-title><source>Am J Respir Crit Care Med</source><year>2017</year><volume>195</volume><issue>7</issue><fpage>942</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1164/rccm.201604-0732OC</pub-id><pub-id pub-id-type="pmid">27779421</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Belloli EA, Degtiar I, Wang X, et al. Parametric response mapping as an imaging biomarker in lung transplant recipients. Am J Respir Crit Care Med. 2017;195(7):942&#x02013;52.<pub-id pub-id-type="pmid">27779421</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Achenbach</surname><given-names>T</given-names></name><name><surname>Weinheimer</surname><given-names>O</given-names></name><name><surname>Buschsieweke</surname><given-names>C</given-names></name><name><surname>Heussel</surname><given-names>CP</given-names></name><name><surname>Thelen</surname><given-names>M</given-names></name><name><surname>Kauczor</surname><given-names>HU</given-names></name></person-group><article-title>Fully automatic detection and quantification of emphysema on thin section MD-CT of the chest by a new and dedicated software</article-title><source>Rofo</source><year>2004</year><volume>176</volume><issue>10</issue><fpage>1409</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1055/s-2004-813530</pub-id><pub-id pub-id-type="pmid">15383971</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Achenbach T, Weinheimer O, Buschsieweke C, Heussel CP, Thelen M, Kauczor HU. Fully automatic detection and quantification of emphysema on thin section MD-CT of the chest by a new and dedicated software. Rofo. 2004;176(10):1409&#x02013;15.<pub-id pub-id-type="pmid">15383971</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Reinhardt</surname><given-names>JM</given-names></name><name><surname>Ding</surname><given-names>K</given-names></name><name><surname>Cao</surname><given-names>K</given-names></name><name><surname>Christensen</surname><given-names>GE</given-names></name><name><surname>Hoffman</surname><given-names>EA</given-names></name><name><surname>Bodas</surname><given-names>SV</given-names></name></person-group><article-title>Registration-based estimates of local lung tissue expansion compared to Xenon CT measures of specific ventilation</article-title><source>Med Image Anal</source><year>2008</year><volume>12</volume><issue>6</issue><fpage>752</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/j.media.2008.03.007</pub-id><pub-id pub-id-type="pmid">18501665</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Reinhardt JM, Ding K, Cao K, Christensen GE, Hoffman EA, Bodas SV. Registration-based estimates of local lung tissue expansion compared to Xenon CT measures of specific ventilation. Med Image Anal. 2008;12(6):752&#x02013;63.<pub-id pub-id-type="pmid">18501665</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="other">Bishop CM, Nasrabadi NM. Pattern recognition and machine learning. Volume 4. New York Springer; 2006.</mixed-citation></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Gutor</surname><given-names>SS</given-names></name><name><surname>Richmond</surname><given-names>BW</given-names></name><name><surname>Du</surname><given-names>RH</given-names></name><etal/></person-group><article-title>Characterization of immunopathology and small airway remodeling in constrictive bronchiolitis</article-title><source>Am J Respir Crit Care Med</source><year>2022</year><volume>206</volume><issue>3</issue><fpage>260</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1164/rccm.202109-2133OC</pub-id><pub-id pub-id-type="pmid">35550018</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Gutor SS, Richmond BW, Du RH, et al. Characterization of immunopathology and small airway remodeling in constrictive bronchiolitis. Am J Respir Crit Care Med. 2022;206(3):260&#x02013;70.<pub-id pub-id-type="pmid">35550018</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Hines</surname><given-names>SE</given-names></name><name><surname>Barnes</surname><given-names>AH</given-names></name><name><surname>Brown</surname><given-names>C</given-names></name><etal/></person-group><article-title>Impulse oscillometry measurement of distal airways obstruction in depleted uranium-exposed Gulf war veterans</article-title><source>Am J Ind Med</source><year>2018</year><volume>61</volume><issue>4</issue><fpage>308</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1002/ajim.22816</pub-id><pub-id pub-id-type="pmid">29424024</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Hines SE, Barnes AH, Brown C, et al. Impulse oscillometry measurement of distal airways obstruction in depleted uranium-exposed Gulf war veterans. Am J Ind Med. 2018;61(4):308&#x02013;16.<pub-id pub-id-type="pmid">29424024</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="other">Kaminsky DA, Simpson SJ, Berger KI et al. Clinical significance and applications of oscillometry. Eur Respir Rev 2022;31(163).</mixed-citation></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Zell-Baran</surname><given-names>LM</given-names></name><name><surname>Humphries</surname><given-names>SM</given-names></name><name><surname>Moore</surname><given-names>CM</given-names></name><etal/></person-group><article-title>Quantitative imaging analysis detects subtle airway abnormalities in symptomatic military deployers</article-title><source>BMC Pulm Med</source><year>2022</year><volume>22</volume><issue>1</issue><fpage>163</fpage><pub-id pub-id-type="doi">10.1186/s12890-022-01960-w</pub-id><pub-id pub-id-type="pmid">35477425</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Zell-Baran LM, Humphries SM, Moore CM, et al. Quantitative imaging analysis detects subtle airway abnormalities in symptomatic military deployers. BMC Pulm Med. 2022;22(1):163.<pub-id pub-id-type="pmid">35477425</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Boes</surname><given-names>JL</given-names></name><name><surname>Bule</surname><given-names>M</given-names></name><name><surname>Hoff</surname><given-names>BA</given-names></name><etal/></person-group><article-title>The impact of sources of variability on parametric response mapping of lung CT scans</article-title><source>Tomography</source><year>2015</year><volume>1</volume><issue>1</issue><fpage>69</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.18383/j.tom.2015.00148</pub-id><pub-id pub-id-type="pmid">26568983</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Boes JL, Bule M, Hoff BA, et al. The impact of sources of variability on parametric response mapping of lung CT scans. Tomography. 2015;1(1):69&#x02013;77.<pub-id pub-id-type="pmid">26568983</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>GS</given-names></name><name><surname>Selwa</surname><given-names>KE</given-names></name><name><surname>Hatt</surname><given-names>C</given-names></name><etal/></person-group><article-title>Multicenter evaluation of parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation</article-title><source>Am J Transpl</source><year>2020</year><volume>20</volume><issue>8</issue><fpage>2198</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1111/ajt.15814</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Cheng GS, Selwa KE, Hatt C, et al. Multicenter evaluation of parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Am J Transpl. 2020;20(8):2198&#x02013;205.</mixed-citation></citation-alternatives></ref></ref-list></back></article>